Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KYNB
326
Kyntra Bio
KYNB
$27.5M
| $32.1M | 0.03% |
21,143
+89
| +0.4% | +$137K |
|
|
BRKL
327
DELISTED
Brookline Bancorp
BRKL
| $31.8M | 0.03% |
1,902,943
-173,964
| -8% | -$3.15M |
|
328
Renasant Corp
RNST
$3.96B
| $31.7M | 0.03% |
770,359
-269
| -0% | -$12.2K |
|
329
Axogen
AXGN
$2.2B
| $31.7M | 0.03% |
861,390
+485,754
| +129% | +$21.2M |
|
330
GrafTech
EAF
$169M
| $31.7M | 0.03% |
162,695
-53,015
| -25% | -$9.99M |
|
|
STAY
331
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $31.4M | 0.03% |
1,553,944
+522,784
| +51% | +$10.9M |
|
332
Johnson Controls International
JCI
$87.8B
| $31.4M | 0.03% |
895,717
-501,624
| -36% | -$18.5M |
|
|
ETP
333
DELISTED
Energy Transfer Partners, L.P.
ETP
| $30.9M | 0.03% |
1,390,384
+285,462
| +26% | +$6.2M |
|
334
Dominion Energy
D
$61.3B
| $30.7M | 0.03% |
+436,701
| New | +$30.9M |
|
335
HealthEquity
HQY
$8.44B
| $30.7M | 0.03% |
324,820
+3,117
| +1% | +$269K |
|
|
GLDD
336
DELISTED
Great Lakes Dredge & Dock
GLDD
| $30.5M | 0.03% |
4,919,792
-48,379
| -1% | -$270K |
|
337
JELD-WEN Holding
JELD
$117M
| $30.3M | 0.03% |
1,228,022
-11,335
| -0.9% | -$302K |
|
|
STMP
338
DELISTED
Stamps.com, Inc.
STMP
| $30M | 0.03% |
132,529
+42,447
| +47% | +$10.6M |
|
339
Inogen
INGN
$174M
| $29.8M | 0.03% |
122,081
+2,511
| +2% | +$581K |
|
340
Enerpac Tool Group
EPAC
$1.86B
| $29.4M | 0.03% |
1,054,228
-5,485
| -0.5% | -$158K |
|
341
BioCryst Pharmaceuticals
BCRX
$2.35B
| $29.4M | 0.03% |
3,850,003
+378,565
| +11% | +$2.54M |
|
|
FLIR
342
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $29.1M | 0.03% |
473,259
-42,308
| -8% | -$2.49M |
|
343
Teradata
TDC
$2.88B
| $29M | 0.03% |
770,187
-66,431
| -8% | -$2.68M |
|
|
MB
344
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $29M | 0.03% |
712,815
+81,475
| +13% | +$3.18M |
|
345
Graphic Packaging
GPK
$3.24B
| $28.7M | 0.03% |
2,045,890
+162,952
| +9% | +$2.35M |
|
346
MaxLinear
MXL
$6.07B
| $28.2M | 0.03% |
1,419,675
+5,609
| +0.4% | +$102K |
|
|
PLYA
347
DELISTED
Playa Hotels & Resorts
PLYA
| $28.2M | 0.03% |
2,930,518
-201,767
| -6% | -$2.07M |
|
|
INXN
348
DELISTED
Interxion Holding N.V.
INXN
| $27.9M | 0.03% |
414,438
-43
| -0% | -$2.79K |
|
349
MGM Resorts International
MGM
$11.7B
| $27.9M | 0.03% |
999,058
-107,892
| -10% | -$3.13M |
|
350
CALL
Gilead Sciences
GILD
$163B
| $27.8M | 0.03% |
+360,000
| New | +$27.2M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.